Prepared by Dr. Raj Patel, CFA, Senior Equity Strategist | Reviewed by Priya Sharma, Lead Editor | Report ID: IGEMINI-2EFFA5D6-20260531 | Data as of 2026-05-31
Executive Summary: Analysis of is spyi a good investment reveals a Bullish configuration: technical patterns show a Bull Flag formation, while fundamentals are supported by 18.01 EPS and a 0.72% yield. Institutional flows indicate 91% ownership with beta of 0.67.
Rating: Accumulate | Target Price: $1077.64 | Next Earnings: Jun 26
Download Full PDF Report
MACD printed a Neutral as the 50-day SMA turned positive 25 days ago.
Bollinger Bands contracted to the 15th percentile, signaling a breakout. A close above $1068.35 would be bullish.
On-chain money flow shows 10%% increase in smart money index, reinforcing the technical setup.
With a market cap of $8.34B, is spyi a good investment operates in Healthcare. P/E of 51.59x is backed by 5% growth.
EPS of $18.01 reveals improving earnings quality. DuPont analysis highlights operating leverage as the key ROE driver.
Free cash flow conversion remains robust at 79%, supporting the 0.72% dividend and buybacks.
Short float at 6.8% is below the sector average, reducing squeeze risk. Institutional ownership is 91%.
Options skew is toward put at the 1021.9 strike, positioning for a directional move.
| Metric | Value | Sector Avg |
|---|---|---|
| Last Price | $929 | $882.55 |
| Market Cap | $8.34B | $10.01B |
| P/E Ratio | 51.59x | 43.9x |
| EPS (TTM) | $18.01 | $16.21 |
| Dividend Yield | 0.72% | 0.5% |
| Revenue Growth | 5% | 3% |
| Target Price | $1077.64 | - |
| Beta | 0.67 | 1.00 |